Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: A secondary analysis from the radiation therapy oncology group database

Journal of Clinical Oncology

Volumn 27, Issue 5, 2009, Pages 733-739

  Blumenthal, Deborah T ^a   Won, Minhee ^b   Mehta, Minesh P ^b   Curran, Walter J ^b   Souhami, Luis ^b   Michalski, Jeff M ^b   Rogers, C Leland ^b   Corn, Benjamin W ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Tel Aviv Sourasky Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARMUSTINE; DACARBAZINE; DIAZIQUONE; MISONIDAZOLE; PACLITAXEL; RECOMBINANT BETA INTERFERON; SEMUSTINE; TAMOXIFEN; THALIDOMIDE; TIRAPAZAMINE; TOPOTECAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG MEGADOSE; GLIOBLASTOMA; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; REFERENCE DATABASE; SECONDARY ANALYSIS; SURVIVAL TIME; THERAPY DELAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; GLIOBLASTOMA; HUMANS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SUPRATENTORIAL NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 59949102929     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.9035     Document Type: Article

References (43)

1. Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant gliomas after surgery. N Engl J Med 303:1323-1329, 1980
2. Keime-Guibert F, Chinot O, Taillandier L, et al: Radiotherapy for glioblastoma in elderly. N Engl J Med 356:1527-1535, 2007
3. Nelson D, Schoenfeld D, Weinstein A, et al: A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: Preliminary results of an RTOG study. Int J Radiat Oncol Biol Phys 9:1143-11151, 1983
4. Souhami L, Seiferheldl W, Brachman D, et al: Randomized comparison of stereotactic radiosur-gery followed by conventional radiotherapy with carmustine to conventional radiotherapy with car-mustine for patients with glioblastoma multiforme: Report of RTOG 93-05. Int J Radiat Oncol Biol Phys 60:853-860, 2004
5. Werner-Wasik M, Scott C, Nelson D, et al: Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiotherapy with carmustine for adults with supratentorial malignant gliomas. Cancer 77:1535-1543, 1996
6. Ky GK, Adjei AA: Principles of chemotherapy, in Chang AE, Ganz PA, Hayes DF, et al (eds): Oncology: An Evidence Based Approach. New York, NY, Springer, 2006, pp 14-16
7. Mackillop WJ, Bates JHT, Withers HR: The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys 34:243-250, 1996
8. Hartsell WF, Recine DC, Griem KL, et al: Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer 76: 2497-2503, 1995
9. Recht A, Come SE, Gelman RS, et al: Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early stage, node-positive breast cancer: Sequencing, timing and outcome. J Clin Oncol 9:1662-1667, 1991
10. Buchholz TA, Austin-Seymour MM, Moe RE, et al: Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 26:23-35, 1993
11. Lee AW, Chan DK, Fowler JF, et al: T1 naso-pharyngeal carcinoma: The effect of waiting time on tumor control. Int J Radiat Oncol Biol Phys 30:1111-1117, 1994
12. Brouha XD, Op DC, Terhaard CH, et al: Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma? Clin Otolaryn-gol 25:215-218, 2000
13. Barton MB, Morgan G, Smee R, et al: Does waiting time affect the outcome of larynx cancer treated by radiotherapy? Radiother Oncol 44:137-141, 1997
14. Choi N, Baumann M, Flentjie M, et al: Predictive factors in radiotherapy for non-small cell lung cancer. Lung Cancer 31:43-56, 2001
15. Tsai CS, Lai CH, Wang CC, et al: The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and post-operative radiotherapy. Gynecol Oncol 75:328-333, 1999
16. Do V, Gebski V, Barton MB: The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol 57:131-136, 2000
17. Chang C, Horton J, Schoenfeld D, et al: Comparison of post-operative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:997-1007, 1983
18. Coughlin C, Scott C, Langer C, et al: Phase II, two arm RTOG trial (94-11) of BCNU plus accelerated hyperfractionated radiotherapy based on tumor volume in the treatment of newly diagnosed surgically ineligible GBM patients. Int J Radiat Oncol Biol Phys 48:1351-1358, 2000
19. Del Rowe J, Scott C, Werner-Wasik M, et al: A single arm, open label phase II study of intravenously administered Tirapazamine plus radiation therapy for malignant glioma. J Clin Oncol 18:1254-1259, 2000
20. Fisher B, Won M, MacDonald D, et al: Phase II study of topotecan plus cranial irradiation for glioblastoma multiforme: Results of RTOG 95-13. Int J Radiat Oncol Biol Phys 53:980-986, 2002
21. Langer C, Ruffer J, Rhodes H, et al: Phase II RTOG trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme. Int J Radiat Oncol Biol Phys 51:113-119, 2001
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 50:163-170, 1966
24. Curran WJ, Scott CB, Horton J, et al: Recursive partitioning analysis of prognostic factors in three RTOG malignant glioma trials. J Natl Cancer Inst 85:704-710, 1993
25. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-229, 1972
26. Mackillop WJ, Fu H, Quirt CF, et al: Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 30:221-228, 1994
27. Morgan GW: A synopsis of radiation oncology in Australia, with particular reference to New South Wales. Aust NZJ Surg 68:225-235, 1998
28. Huang J, Barbera L, Brouwers M, et al: Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21:555-563, 2003
29. Benk V, Joseph L, Fortin P, et al: Effect of delay in initiating radiotherapy for patients with early stage breast cancer. Clin Oncol 16:6-11, 2004
30. Clarke DH, Le MG, Sarrazin D, et al: Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustave Roussy. Int J Radiat Oncol Biol Phys 11:137-145, 1985
31. Vujovic O, Perera F, Dar AR, et al: Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? Int J Radiat Oncol Biol Phys 40:869-874, 1998
32. Froud PJ, Mates D, Jackson JS, et al: Effect of time interval between breast conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys 46:363-372, 2000
33. Ampil FL, Burton GV, Li BD, et al: Radiotherapy with and without chemotherapy after breast conservation surgery for early stage breast cancer: A review of timing. Eur J Gynaecol Oncol 20:254-257, 1999
34. O'Sullivan B, Mackillop W, Grice B, et al: The influence of delay in the initiation of definitive radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 42:S97, 1998 (suppl 1; abstr)
35. Dixit S, Vyas RK, Toparani RB, et al: Surgery versus surgery and post-operative radiotherapy in squamous cell carcinoma of the buccal mucosa: A comparative study. Ann Surg Oncol 5:502-510, 1998
36. Kajanti M, Holsti LR, Holsti P: Radical surgery and post-operative split course radiotherapy in squa-mous cell carcinoma of the mobile tongue: Factors influencing local control and the time to recurrence. Radiother Oncol 22:174-179, 1991
37. Ampil FL, Buechter KJ, Bairnsfather LE, et al: Timing and dosage of post-operative radiotherapy for squamous cell carcinoma of the upper aerodigestive tract. J Oral Maxillofac Surg 51:1194-1197, 1993
38. Bastit L, Blot E, Debourdeau P, et al: Influence of the delay of adjuvant post-operative radiotherapy on relapse and survival in oropharyngeal and hypo-pharyngeal cancers. Int J Radiat Oncol Biol Phys 49:139-146, 2001
39. Work E, Nielsen OS, Bentzen SM, et al: Randomized study of initial versus late chest irradiation combined with chemotherapy in limited stage small cell lung cancer: Aarhus Lung Cancer Group. J Clin Oncol 15:3030-3037, 1997
40. Chinot OL, Barrié M, Fuentes S, et al: Correlation between 0-6-methylguanine DNA me-thyltransferase and survival in inoperable newly diagnosed GBM patients treated with neoadjuvant Temozolomide. J Clin Oncol 25:1470-1475, 2007
41. Hegi ME, Diserens AC, Gorlia T, et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003, 2005
42. Taghian A, Ramsay J, Allalunis-Turner J, et al: Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome in GBM. Int J Radiat Oncol Biol Phys 25:243-249, 1993
43. Peker S, Abacioglu U, Sun I, et al: Irradiation after surgically induced brain injury in the rat: Timing in relation to severity of radiation damage. J Neu-rooncol 70:17-21, 2004